
Higher depressive and manic (symptoms were associated with lower GAF, most strongly among the older participants.

Higher depressive and manic (symptoms were associated with lower GAF, most strongly among the older participants.

It’s time to stop just recommending trigger avoidance strategies to patients. These are the proactive behaviors that will actually help improve migraine.

Previous research has shown that COVID-19 can impact ocular health.

Metabolomic and preclinical studies have indicated that branched-chain amino acids may protect against neurodegenerative diseases.

While the nerve disease is not life threatening, patients may experience considerable poor quality of life and emotional distress.

Patients included in the high-dose group demonstrated statistically significant improvements compared to placebo for MDS-UPDRS total score.

Nearly half of all never C difficile cases are found in nursing home communities.

The overall 90-day cumulative incidences of a first CDI episode was 1.9%.

A new Polish study calls for greater focus on asthma and the link to delirium in older patients, who may face greater mortality risk.

The approval for Biogen’s disease-modifying, anti-amyloid agent aducanumab follows a long regulatory journey.

Patients treated with ustekinumab had significantly more prior biologic use than patients treated with vedolizumab.

A large proportion of HCV patients remain undiagnosed, particularly in the older population.

Older patients who maintained the multi-domain rehabilitation program saw improvements in various markers of physical function.

Females and older patients had higher rates of hospitalizations with CDI than males and younger patients.

An FDA-approved device, provided to eligible patients with age-related macular degeneration, showed ability to detect CNV risks over 5 years.

Late life depression is a known risk factor for dementia, impacting 8-16% in the US.

The study presented at the 2021 AAN Meeting follows the complete response letter issued by the FDA to Acadia Pharmaceuticals due to deficiencies in their sNDA.

New data find significant associations between every five-year earlier onset of diabetes and a higher hazard rate of dementia, in patients aged 35-75 years old.

Anti-VEGF administration did increase the risk of nonocular hemorrhages, mostly in patients with AMD.

The investigators generated a list of 250 genes that are known to regulate individual reactions within the component pathways of the Alzheimer Disease Aberrant Metabolism (ADAM) network.

The cumulative incidence of disease among participants in the low-, medium-, and high-risk tertiles was 31.7%, 47.6%, and 59.8%, respectively.

Researchers examine how biomarkers are differentially mapped to MRI measures of cortical thickness.

Acadia stands by the safety and efficacy of pimavanserin.

If approved, daridorexant would become the first sleep medication to demonstrate an improvement in sleep and daytime functioning.

Increasing OSA severity was associated with increasing markers of obesity.